Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms
Stereotaxis today announced a global collaboration with Abbott to integrate Abbott’s EnSite™ X EP System […]
Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ for the Treatment of the Signs and Symptoms of Dry Eye Disease
Bausch + Lomb, a leading global eye health company dedicated to helping people see better […]
TraceLink Announces Appointment of George Llado, former Merck and Alexion CIO, to Board of Directors
TraceLink, the leading digital network platform company enabling end-to-end product orchestration by connecting more than […]
Chroma Medicine Announces Data Demonstrating the Benefits of Epigenetic Editing for Multiplex Gene Regulation
Chroma Medicine, a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented data demonstrating […]
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics
Shanghai Stock Exchange-listed company HitGen announced today that it has entered into a research agreement […]
Discovery Life Sciences Joins Akoya Biosciences' Global Service Provider Network to Accelerate Immuno-oncology Research
Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, have announced that it has officially […]
Phio Pharmaceuticals Presents Preclinical Study Showing INTASYL™ Treatment of NK Cells More than Doubles Ability to Kill Tumor Cells
Phio Pharmaceuticals, a clinical-stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to […]
Enrique Neumann, Beckman Coulter Diagnostics, on Automation Solutions
In the video, Enrique Neumann, the Field Marketing Manager of Genomics from Beckman Coulter Diagnostics, […]
CANbridge and UMass Chan Medical School Spinal Muscular Atrophy Gene Therapy (CAN203) Improves Lifespan and Motor Function in Mice
CANbridge Pharmaceuticals, a leading China-based global biopharmaceutical company committed to the research, development and commercialization […]
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer
Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more